Format

Send to

Choose Destination
J Med Chem. 1996 Nov 8;39(23):4531-6.

Design, synthesis, and evolution of a novel, selective, and orally bioavailable class of thrombin inhibitors: P1-argininal derivatives incorporating P3-P4 lactam sulfonamide moieties.

Author information

1
Corvas International, Inc., San Diego, California 92121-1102, USA. ed_semple@corvas.com
PMID:
8917639
DOI:
10.1021/jm960572n
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center